Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2024 Earnings Call Transcript March 3, 2025
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter and Full Year 2024 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I’d like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Sharon Klahre: Thank you, operator. Welcome, and thank you all for joining us today for a review of Syndax’s fourth...
